Mon, October 3, 2022
Sun, October 2, 2022
Fri, September 30, 2022
Thu, September 29, 2022
Wed, September 28, 2022
Tue, September 27, 2022
Mon, September 26, 2022
Fri, September 23, 2022
Thu, September 22, 2022
Wed, September 21, 2022
Tue, September 20, 2022
Mon, September 19, 2022

Raghuram Selvaraju Maintained (SPRO) at Strong Buy with Decreased Target to $6 on, Sep 26th, 2022


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. with-decreased-target-to-6-on-sep-26th-2022.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Raghuram Selvaraju of HC Wainwright & Co., Maintained "Spero Therapeutics, Inc." (SPRO) at Strong Buy with Decreased Target from $7 to $6 on, Sep 26th, 2022.

Raghuram has made no other calls on SPRO in the last 4 months.



There is 1 other peer that has a rating on SPRO. Out of the 1 peers that are also analyzing SPRO, 0 agree with Raghuram's Rating of Hold.



This is the rating of the analyst that currently disagrees with Raghuram


  • Josh Schimmer of "Evercore ISI Group" Upgraded from Hold to Buy and Increased Target to $8 on, Friday, September 23rd, 2022

Publication Contributing Sources